| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |